

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | heme biosynthetic process (GO:0006783) | 8.68554102 |
| 2 | porphyrin-containing compound biosynthetic process (GO:0006779) | 8.20175324 |
| 3 | tetrapyrrole biosynthetic process (GO:0033014) | 7.34416322 |
| 4 | heme metabolic process (GO:0042168) | 6.95853176 |
| 5 | porphyrin-containing compound metabolic process (GO:0006778) | 6.55573759 |
| 6 | erythrocyte maturation (GO:0043249) | 6.07622287 |
| 7 | ribosomal small subunit assembly (GO:0000028) | 5.58679715 |
| 8 | erythrocyte development (GO:0048821) | 5.33546918 |
| 9 | DNA deamination (GO:0045006) | 4.87956519 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.78878033 |
| 11 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.72791379 |
| 12 | DNA replication initiation (GO:0006270) | 4.59995368 |
| 13 | DNA strand elongation (GO:0022616) | 4.59995089 |
| 14 | viral transcription (GO:0019083) | 4.58473370 |
| 15 | translational termination (GO:0006415) | 4.40818050 |
| 16 | tetrapyrrole metabolic process (GO:0033013) | 4.36591314 |
| 17 | pigment biosynthetic process (GO:0046148) | 4.34973752 |
| 18 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.23107125 |
| 19 | proteasome assembly (GO:0043248) | 4.04771540 |
| 20 | translational elongation (GO:0006414) | 4.03978830 |
| 21 | telomere maintenance via recombination (GO:0000722) | 3.97171275 |
| 22 | one-carbon compound transport (GO:0019755) | 3.88734805 |
| 23 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.85596660 |
| 24 | DNA replication checkpoint (GO:0000076) | 3.83586692 |
| 25 | ribosomal small subunit biogenesis (GO:0042274) | 3.83275975 |
| 26 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.81221602 |
| 27 | erythrocyte differentiation (GO:0030218) | 3.79232777 |
| 28 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.74752046 |
| 29 | cotranslational protein targeting to membrane (GO:0006613) | 3.71889527 |
| 30 | protein targeting to ER (GO:0045047) | 3.70513892 |
| 31 | DNA unwinding involved in DNA replication (GO:0006268) | 3.70169440 |
| 32 | myeloid cell development (GO:0061515) | 3.69405478 |
| 33 | hemoglobin metabolic process (GO:0020027) | 3.69079999 |
| 34 | maturation of SSU-rRNA (GO:0030490) | 3.66838923 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.65250600 |
| 36 | pigment metabolic process (GO:0042440) | 3.64256603 |
| 37 | CENP-A containing nucleosome assembly (GO:0034080) | 3.60715021 |
| 38 | mitotic recombination (GO:0006312) | 3.60553911 |
| 39 | oxygen transport (GO:0015671) | 3.60192192 |
| 40 | embryonic hemopoiesis (GO:0035162) | 3.59659433 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.57401529 |
| 42 | translational initiation (GO:0006413) | 3.56981916 |
| 43 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.54419474 |
| 44 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.52978077 |
| 45 | protein localization to endoplasmic reticulum (GO:0070972) | 3.50892597 |
| 46 | purine nucleotide salvage (GO:0032261) | 3.48725276 |
| 47 | cellular protein complex disassembly (GO:0043624) | 3.47925736 |
| 48 | viral life cycle (GO:0019058) | 3.40804743 |
| 49 | response to interferon-beta (GO:0035456) | 3.40724397 |
| 50 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.40357039 |
| 51 | telomere maintenance via telomere lengthening (GO:0010833) | 3.39538985 |
| 52 | response to protozoan (GO:0001562) | 3.35317240 |
| 53 | chromatin remodeling at centromere (GO:0031055) | 3.34372215 |
| 54 | granulocyte differentiation (GO:0030851) | 3.34222100 |
| 55 | gas transport (GO:0015669) | 3.33976820 |
| 56 | response to peptidoglycan (GO:0032494) | 3.33781467 |
| 57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.28111817 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.27841047 |
| 59 | positive regulation of antigen processing and presentation (GO:0002579) | 3.26891618 |
| 60 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.22729779 |
| 61 | DNA replication-independent nucleosome organization (GO:0034724) | 3.22729779 |
| 62 | purine-containing compound salvage (GO:0043101) | 3.22330765 |
| 63 | response to lead ion (GO:0010288) | 3.14783237 |
| 64 | kinetochore organization (GO:0051383) | 3.14251470 |
| 65 | protein complex disassembly (GO:0043241) | 3.10934871 |
| 66 | regulation of erythrocyte differentiation (GO:0045646) | 3.10385768 |
| 67 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.07843635 |
| 68 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.07843635 |
| 69 | regulation of chronic inflammatory response (GO:0002676) | 3.07735320 |
| 70 | formation of translation preinitiation complex (GO:0001731) | 3.07480879 |
| 71 | cellular response to interferon-beta (GO:0035458) | 3.06878516 |
| 72 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.06864855 |
| 73 | negative regulation of interleukin-12 production (GO:0032695) | 3.05374507 |
| 74 | ribosomal large subunit biogenesis (GO:0042273) | 3.04123003 |
| 75 | neutrophil activation involved in immune response (GO:0002283) | 3.04044859 |
| 76 | positive regulation of heat generation (GO:0031652) | 3.03545613 |
| 77 | response to insecticide (GO:0017085) | 3.03512361 |
| 78 | iron-sulfur cluster assembly (GO:0016226) | 3.02993890 |
| 79 | metallo-sulfur cluster assembly (GO:0031163) | 3.02993890 |
| 80 | protein localization to chromosome, centromeric region (GO:0071459) | 3.01935813 |
| 81 | kinetochore assembly (GO:0051382) | 3.01504954 |
| 82 | response to methylmercury (GO:0051597) | 2.99894066 |
| 83 | pseudouridine synthesis (GO:0001522) | 2.97446827 |
| 84 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.97316401 |
| 85 | definitive hemopoiesis (GO:0060216) | 2.96196328 |
| 86 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.96182527 |
| 87 | protein localization to kinetochore (GO:0034501) | 2.95373896 |
| 88 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.94581820 |
| 89 | mitotic sister chromatid segregation (GO:0000070) | 2.94139872 |
| 90 | NAD biosynthetic process (GO:0009435) | 2.93048131 |
| 91 | macromolecular complex disassembly (GO:0032984) | 2.91464686 |
| 92 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.91418581 |
| 93 | defense response to protozoan (GO:0042832) | 2.91385476 |
| 94 | translation (GO:0006412) | 2.90541426 |
| 95 | regulation of B cell apoptotic process (GO:0002902) | 2.89689888 |
| 96 | IMP biosynthetic process (GO:0006188) | 2.88076167 |
| 97 | B cell mediated immunity (GO:0019724) | 2.87678418 |
| 98 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.87037499 |
| 99 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86727145 |
| 100 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86309674 |
| 101 | regulation of antigen processing and presentation (GO:0002577) | 2.86028425 |
| 102 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.85668031 |
| 103 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 2.85125171 |
| 104 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.82363012 |
| 105 | megakaryocyte development (GO:0035855) | 2.82175903 |
| 106 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82036381 |
| 107 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.82011621 |
| 108 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.81743382 |
| 109 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.81407827 |
| 110 | cellular response to exogenous dsRNA (GO:0071360) | 2.79958092 |
| 111 | regulation of chemokine biosynthetic process (GO:0045073) | 2.78449067 |
| 112 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.78314449 |
| 113 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.78175881 |
| 114 | rRNA processing (GO:0006364) | 2.75490367 |
| 115 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75430517 |
| 116 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.75412395 |
| 117 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.75133924 |
| 118 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.75133924 |
| 119 | histone exchange (GO:0043486) | 2.72240937 |
| 120 | platelet formation (GO:0030220) | 2.71861659 |
| 121 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.71387083 |
| 122 | meiotic chromosome segregation (GO:0045132) | 2.71089194 |
| 123 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.70357446 |
| 124 | positive regulation of prostaglandin secretion (GO:0032308) | 2.70131808 |
| 125 | rRNA metabolic process (GO:0016072) | 2.69126605 |
| 126 | RNA catabolic process (GO:0006401) | 2.64283953 |
| 127 | regulation of response to osmotic stress (GO:0047484) | 2.64195089 |
| 128 | positive regulation of defense response to virus by host (GO:0002230) | 2.64180767 |
| 129 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.63037607 |
| 130 | superoxide anion generation (GO:0042554) | 2.62443626 |
| 131 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.62376389 |
| 132 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.62180043 |
| 133 | cell cycle G1/S phase transition (GO:0044843) | 2.61951074 |
| 134 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.61951074 |
| 135 | mRNA catabolic process (GO:0006402) | 2.61293460 |
| 136 | ribosome biogenesis (GO:0042254) | 2.60847065 |
| 137 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.60645260 |
| 138 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.60641104 |
| 139 | indole-containing compound catabolic process (GO:0042436) | 2.60639430 |
| 140 | indolalkylamine catabolic process (GO:0046218) | 2.60639430 |
| 141 | tryptophan catabolic process (GO:0006569) | 2.60639430 |
| 142 | telomere organization (GO:0032200) | 2.60112995 |
| 143 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.59961466 |
| 144 | folic acid metabolic process (GO:0046655) | 2.59841396 |
| 145 | telomere maintenance (GO:0000723) | 2.59270923 |
| 146 | nucleobase biosynthetic process (GO:0046112) | 2.59222174 |
| 147 | NIK/NF-kappaB signaling (GO:0038061) | 2.56641725 |
| 148 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.56363710 |
| 149 | deoxyribonucleotide catabolic process (GO:0009264) | 2.56069200 |
| 150 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.56045644 |
| 151 | nucleotide salvage (GO:0043173) | 2.55814534 |
| 152 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.54896367 |
| 153 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.54896367 |
| 154 | NADH dehydrogenase complex assembly (GO:0010257) | 2.54896367 |
| 155 | protein complex biogenesis (GO:0070271) | 2.53729004 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.52500559 |
| 157 | Peyers patch development (GO:0048541) | 2.52332979 |
| 158 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.52332979 |
| 159 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.51247965 |
| 160 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.51164185 |
| 161 | amine catabolic process (GO:0009310) | 2.50649147 |
| 162 | cellular biogenic amine catabolic process (GO:0042402) | 2.50649147 |
| 163 | positive regulation of granulocyte differentiation (GO:0030854) | 2.49678752 |
| 164 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.49022080 |
| 165 | mature B cell differentiation involved in immune response (GO:0002313) | 2.48672383 |
| 166 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.48574552 |
| 167 | regulation of T-helper cell differentiation (GO:0045622) | 2.47056408 |
| 168 | response to ATP (GO:0033198) | 2.45346122 |
| 169 | autophagic vacuole fusion (GO:0000046) | 2.44725746 |
| 170 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.44665395 |
| 171 | regulation of fever generation (GO:0031620) | 2.44577405 |
| 172 | type I interferon signaling pathway (GO:0060337) | 2.44185857 |
| 173 | cellular response to type I interferon (GO:0071357) | 2.44185857 |
| 174 | kynurenine metabolic process (GO:0070189) | 2.43419022 |
| 175 | response to type I interferon (GO:0034340) | 2.42675415 |
| 176 | germinal center formation (GO:0002467) | 2.42001563 |
| 177 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.41952537 |
| 178 | tryptophan metabolic process (GO:0006568) | 2.41261148 |
| 179 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.40801147 |
| 180 | regulation of mast cell activation (GO:0033003) | 2.40209721 |
| 181 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.39650897 |
| 182 | deoxyribose phosphate catabolic process (GO:0046386) | 2.37200796 |
| 183 | regulation of interferon-alpha production (GO:0032647) | 2.36721793 |
| 184 | protoporphyrinogen IX metabolic process (GO:0046501) | 11.0575889 |
| 185 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 10.5774095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.79828332 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 5.12645762 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.46677240 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.39674395 |
| 5 | GATA1_22025678_ChIP-Seq_K562_Human | 3.31370573 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.24212606 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.20185997 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74802845 |
| 9 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71112764 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.65052337 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.63263020 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.50878876 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.50314994 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.49240246 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46718486 |
| 16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.39950961 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.35703437 |
| 18 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.34295517 |
| 19 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.30488080 |
| 20 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.27767640 |
| 21 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.24012695 |
| 22 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.17215958 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.14849611 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.11866879 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.11089515 |
| 26 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.09059810 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.05004774 |
| 28 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.04070481 |
| 29 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.00919004 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.98845883 |
| 31 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92278620 |
| 32 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90835123 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.88660839 |
| 34 | GATA1_19941826_ChIP-Seq_K562_Human | 1.86832325 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.85974639 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.85055963 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84284424 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83467473 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77605918 |
| 40 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.75724621 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74903809 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.73818985 |
| 43 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.72810227 |
| 44 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72192258 |
| 45 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.70530582 |
| 46 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70315577 |
| 47 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.68496768 |
| 48 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.67502480 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.65913973 |
| 50 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.64002909 |
| 51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63396771 |
| 52 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.62748575 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.59593467 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57241505 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56947101 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55233783 |
| 57 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.53214967 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50553215 |
| 59 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.49890208 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49560156 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49097830 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47754876 |
| 63 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47176766 |
| 64 | MYB_26560356_Chip-Seq_TH2_Human | 1.45080594 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.44655372 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.42583579 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40114061 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.37824218 |
| 69 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36376962 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.35381914 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34414457 |
| 72 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.33406801 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32979060 |
| 74 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.32970554 |
| 75 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.32558545 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.31360789 |
| 77 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31126968 |
| 78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30003703 |
| 79 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29416329 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27776042 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27195012 |
| 82 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26829078 |
| 83 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26347790 |
| 84 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26183889 |
| 85 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.25144122 |
| 86 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.24137704 |
| 87 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23148575 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22322166 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22171365 |
| 90 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22039144 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20873121 |
| 92 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20614163 |
| 93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.19828092 |
| 94 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16912543 |
| 95 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16773532 |
| 96 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16764869 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16538436 |
| 98 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.16333107 |
| 99 | MYB_26560356_Chip-Seq_TH1_Human | 1.16080755 |
| 100 | P300_27268052_Chip-Seq_Bcells_Human | 1.15265311 |
| 101 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13380230 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 1.13190842 |
| 103 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13184770 |
| 104 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12932434 |
| 105 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.09177505 |
| 106 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08951835 |
| 107 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08576599 |
| 108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07604337 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05880526 |
| 110 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05841195 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05119840 |
| 112 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04697813 |
| 113 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04621421 |
| 114 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.02937869 |
| 115 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02071728 |
| 116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.01166788 |
| 117 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.01127697 |
| 118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99981079 |
| 119 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.99849036 |
| 120 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99440340 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.99151633 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99113127 |
| 123 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.99060198 |
| 124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98349351 |
| 125 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97834125 |
| 126 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96276740 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94857395 |
| 128 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.94822201 |
| 129 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94515745 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92914272 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.92524901 |
| 132 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92021052 |
| 133 | MAF_26560356_Chip-Seq_TH1_Human | 0.90542643 |
| 134 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.88667529 |
| 135 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88343246 |
| 136 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87601457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 8.52452645 |
| 2 | MP0004147_increased_porphyrin_level | 8.31764413 |
| 3 | MP0003303_peritoneal_inflammation | 4.18697152 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.74957772 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.49123812 |
| 6 | MP0001545_abnormal_hematopoietic_system | 3.43117344 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 3.43117344 |
| 8 | MP0002396_abnormal_hematopoietic_system | 3.39228542 |
| 9 | MP0010094_abnormal_chromosome_stability | 3.24714738 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 2.86574386 |
| 11 | MP0003077_abnormal_cell_cycle | 2.73509423 |
| 12 | MP0003436_decreased_susceptibility_to | 2.64606000 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 2.58660864 |
| 14 | MP0008057_abnormal_DNA_replication | 2.43084574 |
| 15 | MP0006082_CNS_inflammation | 2.23205370 |
| 16 | MP0008058_abnormal_DNA_repair | 2.12939208 |
| 17 | MP0006054_spinal_hemorrhage | 2.08567318 |
| 18 | MP0000490_abnormal_crypts_of | 2.05077909 |
| 19 | MP0002132_abnormal_respiratory_system | 2.04731332 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.97521220 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.95684585 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.93737821 |
| 23 | MP0002398_abnormal_bone_marrow | 1.80533695 |
| 24 | MP0001790_abnormal_immune_system | 1.78252161 |
| 25 | MP0005387_immune_system_phenotype | 1.78252161 |
| 26 | MP0002254_reproductive_system_inflammat | 1.78161266 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 1.78014622 |
| 28 | MP0008007_abnormal_cellular_replicative | 1.69186932 |
| 29 | MP0003186_abnormal_redox_activity | 1.66655390 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.64898723 |
| 31 | MP0005083_abnormal_biliary_tract | 1.61633043 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.59310182 |
| 33 | MP0002722_abnormal_immune_system | 1.58187950 |
| 34 | MP0000685_abnormal_immune_system | 1.57549115 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.57007454 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.56103527 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.55459477 |
| 38 | MP0003195_calcinosis | 1.48509068 |
| 39 | MP0000343_altered_response_to | 1.43215385 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.39244764 |
| 41 | MP0002138_abnormal_hepatobiliary_system | 1.39062415 |
| 42 | * MP0002429_abnormal_blood_cell | 1.38238169 |
| 43 | MP0008004_abnormal_stomach_pH | 1.35911168 |
| 44 | MP0005671_abnormal_response_to | 1.34542060 |
| 45 | MP0008995_early_reproductive_senescence | 1.33513709 |
| 46 | MP0000313_abnormal_cell_death | 1.33494441 |
| 47 | MP0003075_altered_response_to | 1.33127692 |
| 48 | MP0001845_abnormal_inflammatory_respons | 1.29146398 |
| 49 | MP0008932_abnormal_embryonic_tissue | 1.25645813 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.25300389 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.23058637 |
| 52 | MP0000350_abnormal_cell_proliferation | 1.22229744 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.21550014 |
| 54 | MP0000372_irregular_coat_pigmentation | 1.21421454 |
| 55 | MP0005410_abnormal_fertilization | 1.20045183 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.15373818 |
| 57 | MP0003786_premature_aging | 1.14792392 |
| 58 | MP0004510_myositis | 1.14588386 |
| 59 | MP0009379_abnormal_foot_pigmentation | 1.14284310 |
| 60 | MP0003724_increased_susceptibility_to | 1.10590910 |
| 61 | MP0005451_abnormal_body_composition | 1.10118009 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.09483580 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.09070372 |
| 64 | MP0002095_abnormal_skin_pigmentation | 1.08540386 |
| 65 | MP0010307_abnormal_tumor_latency | 1.07523853 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.06098794 |
| 67 | MP0008775_abnormal_heart_ventricle | 1.04578948 |
| 68 | MP0005310_abnormal_salivary_gland | 1.03695612 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.01441345 |
| 70 | MP0000716_abnormal_immune_system | 1.00786419 |
| 71 | MP0004947_skin_inflammation | 0.99889224 |
| 72 | MP0001835_abnormal_antigen_presentation | 0.99321085 |
| 73 | MP0003567_abnormal_fetal_cardiomyocyte | 0.97724218 |
| 74 | MP0001730_embryonic_growth_arrest | 0.96279048 |
| 75 | MP0001764_abnormal_homeostasis | 0.93288128 |
| 76 | MP0001663_abnormal_digestive_system | 0.92863092 |
| 77 | MP0002080_prenatal_lethality | 0.92709692 |
| 78 | MP0008872_abnormal_physiological_respon | 0.91827420 |
| 79 | MP0005025_abnormal_response_to | 0.91630060 |
| 80 | MP0005535_abnormal_body_temperature | 0.91269141 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 0.91064590 |
| 82 | MP0003763_abnormal_thymus_physiology | 0.89325727 |
| 83 | MP0001853_heart_inflammation | 0.89060607 |
| 84 | MP0003300_gastrointestinal_ulcer | 0.88347890 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.87911289 |
| 86 | MP0000358_abnormal_cell_content/ | 0.87680423 |
| 87 | MP0005266_abnormal_metabolism | 0.87401099 |
| 88 | MP0003646_muscle_fatigue | 0.87296437 |
| 89 | MP0008260_abnormal_autophagy | 0.83837794 |
| 90 | MP0002420_abnormal_adaptive_immunity | 0.83576557 |
| 91 | MP0008770_decreased_survivor_rate | 0.82883439 |
| 92 | MP0001819_abnormal_immune_cell | 0.82479544 |
| 93 | MP0009931_abnormal_skin_appearance | 0.82398812 |
| 94 | MP0005166_decreased_susceptibility_to | 0.81545093 |
| 95 | MP0006035_abnormal_mitochondrial_morpho | 0.79710654 |
| 96 | MP0002405_respiratory_system_inflammati | 0.79665657 |
| 97 | MP0001501_abnormal_sleep_pattern | 0.79346966 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76484167 |
| 99 | MP0009785_altered_susceptibility_to | 0.76231298 |
| 100 | MP0001800_abnormal_humoral_immune | 0.75942769 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.74882326 |
| 102 | MP0002723_abnormal_immune_serum | 0.74159773 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.73787902 |
| 104 | MP0008469_abnormal_protein_level | 0.73623105 |
| 105 | MP0001697_abnormal_embryo_size | 0.73265588 |
| 106 | MP0003866_abnormal_defecation | 0.72701030 |
| 107 | MP0000598_abnormal_liver_morphology | 0.72651362 |
| 108 | MP0009840_abnormal_foam_cell | 0.72168565 |
| 109 | MP0002452_abnormal_antigen_presenting | 0.71970322 |
| 110 | MP0000749_muscle_degeneration | 0.71164549 |
| 111 | MP0009764_decreased_sensitivity_to | 0.70912099 |
| 112 | MP0002166_altered_tumor_susceptibility | 0.70260558 |
| 113 | MP0005165_increased_susceptibility_to | 0.69155838 |
| 114 | MP0000604_amyloidosis | 0.69029858 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.68910697 |
| 116 | MP0009278_abnormal_bone_marrow | 0.68609776 |
| 117 | MP0005647_abnormal_sex_gland | 0.68074828 |
| 118 | MP0001919_abnormal_reproductive_system | 0.67901837 |
| 119 | MP0003718_maternal_effect | 0.67526907 |
| 120 | MP0002086_abnormal_extraembryonic_tissu | 0.66355211 |
| 121 | MP0005000_abnormal_immune_tolerance | 0.65860322 |
| 122 | MP0006292_abnormal_olfactory_placode | 0.65081785 |
| 123 | MP0002102_abnormal_ear_morphology | 0.63780099 |
| 124 | MP0002139_abnormal_hepatobiliary_system | 0.63744755 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.63685555 |
| 126 | MP0009763_increased_sensitivity_to | 0.63447258 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.62233839 |
| 128 | MP0000015_abnormal_ear_pigmentation | 0.61638435 |
| 129 | MP0000609_abnormal_liver_physiology | 0.61250824 |
| 130 | MP0001529_abnormal_vocalization | 0.60440844 |
| 131 | MP0002419_abnormal_innate_immunity | 0.58643036 |
| 132 | MP0003172_abnormal_lysosome_physiology | 0.58572713 |
| 133 | MP0005384_cellular_phenotype | 0.58507307 |
| 134 | MP0005621_abnormal_cell_physiology | 0.58492238 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.56778205 |
| 136 | MP0010155_abnormal_intestine_physiology | 0.55645525 |
| 137 | MP0001873_stomach_inflammation | 0.55453976 |
| 138 | MP0001672_abnormal_embryogenesis/_devel | 0.54797300 |
| 139 | MP0005380_embryogenesis_phenotype | 0.54797300 |
| 140 | MP0000858_altered_metastatic_potential | 0.52912776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Poikilocytosis (HP:0004447) | 8.46452477 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 7.30086988 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.95653401 |
| 4 | Acanthocytosis (HP:0001927) | 6.59793318 |
| 5 | Reticulocytosis (HP:0001923) | 6.05542757 |
| 6 | Petechiae (HP:0000967) | 5.23865646 |
| 7 | Abnormality of reticulocytes (HP:0004312) | 5.13227046 |
| 8 | Hyperbilirubinemia (HP:0002904) | 4.34524100 |
| 9 | Prolonged bleeding time (HP:0003010) | 4.26409078 |
| 10 | Birth length less than 3rd percentile (HP:0003561) | 4.23226050 |
| 11 | Hypochromic microcytic anemia (HP:0004840) | 4.22265137 |
| 12 | Diaphragmatic weakness (HP:0009113) | 4.19357376 |
| 13 | Paralysis (HP:0003470) | 4.00633171 |
| 14 | Stomatitis (HP:0010280) | 3.94779453 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.89599126 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.89599126 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.89599126 |
| 18 | Cholelithiasis (HP:0001081) | 3.87153828 |
| 19 | Pallor (HP:0000980) | 3.84316142 |
| 20 | Aplastic anemia (HP:0001915) | 3.83017900 |
| 21 | Increased serum ferritin (HP:0003281) | 3.57626665 |
| 22 | Reticulocytopenia (HP:0001896) | 3.49110226 |
| 23 | Macrocytic anemia (HP:0001972) | 3.47702769 |
| 24 | Abnormal gallbladder morphology (HP:0012437) | 3.38830905 |
| 25 | Microcytic anemia (HP:0001935) | 3.34488782 |
| 26 | Cutaneous photosensitivity (HP:0000992) | 3.32976550 |
| 27 | Polycythemia (HP:0001901) | 3.12927015 |
| 28 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09441855 |
| 29 | Epistaxis (HP:0000421) | 3.05297725 |
| 30 | Abnormality of iron homeostasis (HP:0011031) | 3.04387011 |
| 31 | Hypochromic anemia (HP:0001931) | 3.02892793 |
| 32 | Insomnia (HP:0100785) | 2.92139727 |
| 33 | Abnormal hemoglobin (HP:0011902) | 2.90829674 |
| 34 | Purpura (HP:0000979) | 2.88941374 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 2.88207937 |
| 36 | Short middle phalanx of the 5th finger (HP:0004220) | 2.86553764 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.86389984 |
| 38 | Myositis (HP:0100614) | 2.83819029 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 2.78493814 |
| 40 | Obstructive lung disease (HP:0006536) | 2.78493814 |
| 41 | Hypertensive crisis (HP:0100735) | 2.74246625 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73116090 |
| 43 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.71275639 |
| 44 | Ileus (HP:0002595) | 2.67312748 |
| 45 | Acute necrotizing encephalopathy (HP:0006965) | 2.64999954 |
| 46 | Acute encephalopathy (HP:0006846) | 2.63872412 |
| 47 | Nausea (HP:0002018) | 2.63641378 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.62639312 |
| 49 | Abnormal platelet function (HP:0011869) | 2.60803793 |
| 50 | Impaired platelet aggregation (HP:0003540) | 2.60803793 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.60600774 |
| 52 | Increased CSF lactate (HP:0002490) | 2.59510262 |
| 53 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58157240 |
| 54 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58157240 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.50116536 |
| 56 | Optic neuritis (HP:0100653) | 2.50116536 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.43402048 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.39073062 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.38597247 |
| 60 | Orchitis (HP:0100796) | 2.38483825 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.36589056 |
| 62 | Hyperthyroidism (HP:0000836) | 2.35587333 |
| 63 | Oral leukoplakia (HP:0002745) | 2.34676153 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.34169986 |
| 65 | Increased IgM level (HP:0003496) | 2.31426768 |
| 66 | Thrombocytosis (HP:0001894) | 2.29943410 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.29163827 |
| 68 | Cholecystitis (HP:0001082) | 2.29163827 |
| 69 | Pustule (HP:0200039) | 2.28685095 |
| 70 | IgM deficiency (HP:0002850) | 2.28435681 |
| 71 | Abnormality of the gallbladder (HP:0005264) | 2.28140996 |
| 72 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.23766968 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.23625198 |
| 74 | Recurrent bacterial skin infections (HP:0005406) | 2.21615385 |
| 75 | Type I transferrin isoform profile (HP:0003642) | 2.21367682 |
| 76 | Reduced antithrombin III activity (HP:0001976) | 2.21139906 |
| 77 | Progressive macrocephaly (HP:0004481) | 2.20191508 |
| 78 | 3-Methylglutaconic aciduria (HP:0003535) | 2.18556147 |
| 79 | Osteomalacia (HP:0002749) | 2.16982916 |
| 80 | Panhypogammaglobulinemia (HP:0003139) | 2.16182566 |
| 81 | Breast hypoplasia (HP:0003187) | 2.14358211 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.11232917 |
| 83 | Myelodysplasia (HP:0002863) | 2.11050330 |
| 84 | Hepatosplenomegaly (HP:0001433) | 2.10677620 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.10485522 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.10156713 |
| 87 | Albinism (HP:0001022) | 2.09256241 |
| 88 | Mediastinal lymphadenopathy (HP:0100721) | 2.07658382 |
| 89 | Attenuation of retinal blood vessels (HP:0007843) | 2.06483160 |
| 90 | Increased hepatocellular lipid droplets (HP:0006565) | 2.05488442 |
| 91 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.04040367 |
| 92 | Chronic otitis media (HP:0000389) | 2.02880631 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.02726072 |
| 94 | Hyponatremia (HP:0002902) | 2.02712565 |
| 95 | Hepatocellular necrosis (HP:0001404) | 2.02281904 |
| 96 | Abnormal spermatogenesis (HP:0008669) | 2.02066359 |
| 97 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 13.5961960 |
| 98 | Recurrent viral infections (HP:0004429) | 1.99502154 |
| 99 | Lactic acidosis (HP:0003128) | 1.98532471 |
| 100 | Increased mean platelet volume (HP:0011877) | 1.97720696 |
| 101 | Dicarboxylic aciduria (HP:0003215) | 1.96739631 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.96739631 |
| 103 | Microretrognathia (HP:0000308) | 1.96143483 |
| 104 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.95181840 |
| 105 | Pancytopenia (HP:0001876) | 1.94943424 |
| 106 | Abnormality of the prostate (HP:0008775) | 1.93265424 |
| 107 | Abnormality of dental color (HP:0011073) | 1.92961224 |
| 108 | Delusions (HP:0000746) | 1.92897342 |
| 109 | Increased serum lactate (HP:0002151) | 1.92455603 |
| 110 | Muscle fiber atrophy (HP:0100295) | 1.92326484 |
| 111 | Multiple enchondromatosis (HP:0005701) | 1.91731573 |
| 112 | Encephalitis (HP:0002383) | 1.90790573 |
| 113 | Type 2 muscle fiber atrophy (HP:0003554) | 1.90730694 |
| 114 | Hepatic necrosis (HP:0002605) | 1.89992963 |
| 115 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.89917187 |
| 116 | Mutism (HP:0002300) | 1.89745693 |
| 117 | Seborrheic dermatitis (HP:0001051) | 1.88798468 |
| 118 | Loss of speech (HP:0002371) | 1.87446260 |
| 119 | Respiratory failure (HP:0002878) | 1.86000190 |
| 120 | Cerebral hypomyelination (HP:0006808) | 1.85937548 |
| 121 | Keratoconjunctivitis (HP:0001096) | 1.85611713 |
| 122 | Episodic fever (HP:0001954) | 1.85041168 |
| 123 | Granulocytopenia (HP:0001913) | 1.84075047 |
| 124 | Anorexia (HP:0002039) | 1.83861084 |
| 125 | Cerebral palsy (HP:0100021) | 1.83826144 |
| 126 | Abnormality of T cell physiology (HP:0011840) | 1.82561622 |
| 127 | Progressive microcephaly (HP:0000253) | 1.80306340 |
| 128 | Basal cell carcinoma (HP:0002671) | 1.79928530 |
| 129 | Increased intramyocellular lipid droplets (HP:0012240) | 1.77384442 |
| 130 | Leukocytosis (HP:0001974) | 1.76466420 |
| 131 | Poor head control (HP:0002421) | 1.75834955 |
| 132 | Menorrhagia (HP:0000132) | 1.74117423 |
| 133 | Hypoplasia of the pons (HP:0012110) | 1.74063375 |
| 134 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.73619982 |
| 135 | Hepatocellular carcinoma (HP:0001402) | 1.72720086 |
| 136 | Urticaria (HP:0001025) | 1.71587702 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.70991650 |
| 138 | Carpal bone hypoplasia (HP:0001498) | 1.68222041 |
| 139 | Azoospermia (HP:0000027) | 1.66470184 |
| 140 | Abnormality of sodium homeostasis (HP:0010931) | 1.66214216 |
| 141 | Chromsome breakage (HP:0040012) | 1.65908813 |
| 142 | Abnormality of chromosome stability (HP:0003220) | 1.64301915 |
| 143 | Microvesicular hepatic steatosis (HP:0001414) | 1.62642423 |
| 144 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.62174834 |
| 145 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.62174834 |
| 146 | Abnormal protein glycosylation (HP:0012346) | 1.62174834 |
| 147 | Abnormal glycosylation (HP:0012345) | 1.62174834 |
| 148 | Bone marrow hypocellularity (HP:0005528) | 1.61726720 |
| 149 | Abnormality of the pons (HP:0007361) | 1.60317715 |
| 150 | Mitochondrial inheritance (HP:0001427) | 1.59258460 |
| 151 | Small intestinal stenosis (HP:0012848) | 1.57787857 |
| 152 | Duodenal stenosis (HP:0100867) | 1.57787857 |
| 153 | Exertional dyspnea (HP:0002875) | 1.56698320 |
| 154 | Rough bone trabeculation (HP:0100670) | 1.56003830 |
| 155 | Hypopigmented skin patches (HP:0001053) | 1.54830097 |
| 156 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.54388665 |
| 157 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.54340355 |
| 158 | Increased muscle lipid content (HP:0009058) | 1.54312225 |
| 159 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.53388430 |
| 160 | 11 pairs of ribs (HP:0000878) | 1.52723595 |
| 161 | Progressive muscle weakness (HP:0003323) | 1.52348757 |
| 162 | Patellar aplasia (HP:0006443) | 1.52119036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 4.69120771 |
| 2 | NME2 | 3.71755192 |
| 3 | WEE1 | 3.52969828 |
| 4 | CDC7 | 3.45749322 |
| 5 | BUB1 | 3.08284214 |
| 6 | STK16 | 2.65757659 |
| 7 | TLK1 | 2.61268171 |
| 8 | VRK1 | 2.55417774 |
| 9 | IRAK3 | 2.52803127 |
| 10 | MAP4K2 | 2.47910175 |
| 11 | ADRBK2 | 2.47302867 |
| 12 | TXK | 2.41780519 |
| 13 | DYRK3 | 2.36099254 |
| 14 | NEK2 | 2.32491300 |
| 15 | BRSK1 | 2.32238095 |
| 16 | BRSK2 | 2.26326930 |
| 17 | RIPK4 | 2.11876708 |
| 18 | ACVR1B | 2.00862539 |
| 19 | NUAK1 | 1.96541672 |
| 20 | MAP3K14 | 1.93465131 |
| 21 | CCNB1 | 1.91668691 |
| 22 | STK4 | 1.83920565 |
| 23 | GRK7 | 1.82405933 |
| 24 | SCYL2 | 1.79751228 |
| 25 | TESK2 | 1.78896096 |
| 26 | VRK2 | 1.71697860 |
| 27 | NEK1 | 1.69727427 |
| 28 | CDK19 | 1.64122390 |
| 29 | MUSK | 1.62519652 |
| 30 | BMPR2 | 1.55095785 |
| 31 | PIM2 | 1.54982430 |
| 32 | MAP2K3 | 1.49099353 |
| 33 | MAP4K1 | 1.48947962 |
| 34 | MAP3K11 | 1.40655235 |
| 35 | PIM1 | 1.40378133 |
| 36 | AURKB | 1.34890682 |
| 37 | STK10 | 1.33451240 |
| 38 | PLK1 | 1.32853089 |
| 39 | ZAK | 1.29252462 |
| 40 | MAPKAPK5 | 1.27882929 |
| 41 | TSSK6 | 1.23694729 |
| 42 | CDK7 | 1.23500988 |
| 43 | FES | 1.23077610 |
| 44 | SRPK1 | 1.22444429 |
| 45 | IRAK4 | 1.22058050 |
| 46 | ATR | 1.21550260 |
| 47 | EIF2AK3 | 1.15498094 |
| 48 | EEF2K | 1.14953417 |
| 49 | FRK | 1.11295854 |
| 50 | MAP3K3 | 1.10462994 |
| 51 | CDK8 | 1.10459603 |
| 52 | KDR | 1.10357089 |
| 53 | AURKA | 1.09375321 |
| 54 | CDK4 | 1.05824540 |
| 55 | KIT | 1.04372330 |
| 56 | RPS6KB2 | 1.04144788 |
| 57 | TNK2 | 1.03057905 |
| 58 | MAP3K8 | 1.01205741 |
| 59 | TTK | 1.00712453 |
| 60 | CHUK | 1.00088346 |
| 61 | MAPK11 | 0.98463031 |
| 62 | ERN1 | 0.96316482 |
| 63 | MKNK1 | 0.94137550 |
| 64 | SYK | 0.92682040 |
| 65 | CHEK2 | 0.91252716 |
| 66 | MAP3K6 | 0.91212857 |
| 67 | MST4 | 0.90016139 |
| 68 | PDK2 | 0.88901257 |
| 69 | TGFBR1 | 0.88428415 |
| 70 | IRAK1 | 0.88049113 |
| 71 | LRRK2 | 0.87069466 |
| 72 | IKBKB | 0.83162612 |
| 73 | RPS6KA5 | 0.81788463 |
| 74 | MAP3K10 | 0.81388597 |
| 75 | LCK | 0.80473357 |
| 76 | INSRR | 0.79778899 |
| 77 | DAPK1 | 0.78751075 |
| 78 | TBK1 | 0.77389661 |
| 79 | MAP2K6 | 0.77204422 |
| 80 | ABL2 | 0.74519991 |
| 81 | TNIK | 0.74030818 |
| 82 | ITK | 0.73353126 |
| 83 | TYK2 | 0.72969566 |
| 84 | BMX | 0.72786611 |
| 85 | TEC | 0.72371768 |
| 86 | JAK2 | 0.71623851 |
| 87 | MAP3K5 | 0.71609783 |
| 88 | LYN | 0.71390685 |
| 89 | ZAP70 | 0.70621546 |
| 90 | FLT3 | 0.70539102 |
| 91 | MKNK2 | 0.70076867 |
| 92 | PRKCQ | 0.69862996 |
| 93 | NME1 | 0.69481717 |
| 94 | TAOK3 | 0.69473676 |
| 95 | DAPK2 | 0.69307945 |
| 96 | GRK6 | 0.68910474 |
| 97 | BCKDK | 0.68540875 |
| 98 | CHEK1 | 0.68345764 |
| 99 | BTK | 0.67178502 |
| 100 | JAK3 | 0.66687379 |
| 101 | HCK | 0.66156583 |
| 102 | CSF1R | 0.65453318 |
| 103 | TAOK1 | 0.64166811 |
| 104 | EIF2AK2 | 0.63946938 |
| 105 | PLK4 | 0.60920561 |
| 106 | MAP2K2 | 0.60770430 |
| 107 | RPS6KA4 | 0.59526398 |
| 108 | BLK | 0.58841870 |
| 109 | PKN1 | 0.57830853 |
| 110 | PLK3 | 0.57152892 |
| 111 | MAP3K1 | 0.56516042 |
| 112 | ATM | 0.55310409 |
| 113 | CSNK2A1 | 0.54463648 |
| 114 | TGFBR2 | 0.53888959 |
| 115 | HIPK2 | 0.53386722 |
| 116 | CAMKK2 | 0.51196166 |
| 117 | IKBKE | 0.50468738 |
| 118 | CSNK2A2 | 0.50221091 |
| 119 | MATK | 0.49334086 |
| 120 | PASK | 0.49014835 |
| 121 | MAPK3 | 0.47616907 |
| 122 | DYRK2 | 0.47390499 |
| 123 | CSK | 0.47274696 |
| 124 | BMPR1B | 0.44316511 |
| 125 | MARK3 | 0.44158984 |
| 126 | PKN2 | 0.43821318 |
| 127 | CLK1 | 0.43791934 |
| 128 | MAPK13 | 0.42550086 |
| 129 | CDK2 | 0.42538114 |
| 130 | GRK1 | 0.42198874 |
| 131 | MAPKAPK3 | 0.41090467 |
| 132 | ADRBK1 | 0.39603301 |
| 133 | WNK4 | 0.38508749 |
| 134 | TAOK2 | 0.38249523 |
| 135 | PAK1 | 0.37389879 |
| 136 | CSNK1G3 | 0.36513472 |
| 137 | RAF1 | 0.35737198 |
| 138 | TIE1 | 0.35022800 |
| 139 | CDK6 | 0.34725373 |
| 140 | ILK | 0.34500649 |
| 141 | FGR | 0.33089180 |
| 142 | RPS6KA6 | 0.33048274 |
| 143 | BRAF | 0.32439502 |
| 144 | TRPM7 | 0.32042476 |
| 145 | MAPK4 | 0.30292985 |
| 146 | ABL1 | 0.29913426 |
| 147 | CDK1 | 0.29527785 |
| 148 | STK24 | 0.28737477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.44041579 |
| 2 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 5.21706333 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 4.24346626 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.53251794 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.88398976 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.83417769 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.83048618 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 2.73399693 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.63070032 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.58582490 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.55922829 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.48145815 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.48130389 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.44692684 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 2.43804995 |
| 16 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.40633264 |
| 17 | Spliceosome_Homo sapiens_hsa03040 | 2.39718968 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27528643 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.23604365 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.19017586 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13857763 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.10712282 |
| 23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.08741600 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.02166941 |
| 25 | RNA transport_Homo sapiens_hsa03013 | 2.00617407 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.92197288 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.84257795 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.73510083 |
| 29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.68329841 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.67108624 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.56256917 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.54977733 |
| 33 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.52751783 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.46574279 |
| 35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.43352672 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42693286 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39497719 |
| 38 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38437608 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38118695 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.35251029 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33321705 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.31773729 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.31605329 |
| 44 | RNA degradation_Homo sapiens_hsa03018 | 1.30903711 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.19137197 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.17926702 |
| 47 | Alcoholism_Homo sapiens_hsa05034 | 1.11792219 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10768372 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06761489 |
| 50 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04519543 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03410022 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98488360 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95761654 |
| 54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93544113 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92730048 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90136812 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87319278 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86101897 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.83935284 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.82926595 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.81700203 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78202276 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77629952 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77334047 |
| 65 | Protein export_Homo sapiens_hsa03060 | 0.77266997 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.76081784 |
| 67 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.75546740 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71731193 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.71701279 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71700059 |
| 71 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69194213 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.68336330 |
| 73 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67053007 |
| 74 | Malaria_Homo sapiens_hsa05144 | 0.66798950 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66675616 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.66585534 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66444763 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65707302 |
| 79 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.65238695 |
| 80 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.64210097 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.63276833 |
| 82 | Phagosome_Homo sapiens_hsa04145 | 0.62103366 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60622516 |
| 84 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60583283 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59850163 |
| 86 | Measles_Homo sapiens_hsa05162 | 0.57907179 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56659883 |
| 88 | Phototransduction_Homo sapiens_hsa04744 | 0.54646814 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54557084 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52078274 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52057893 |
| 92 | Legionellosis_Homo sapiens_hsa05134 | 0.52019235 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51936092 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.51706051 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.49853246 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49590328 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46115282 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46009795 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45344581 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44628298 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | 0.43929571 |
| 102 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43166510 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.41205232 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.40689218 |
| 105 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40290844 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39250886 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.39171911 |
| 108 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38566051 |
| 109 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38372306 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37869158 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37799550 |
| 112 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37473649 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.36521094 |
| 114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36220051 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35551784 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35339909 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33801411 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29458885 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.29376522 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.28934374 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28921475 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.27104253 |
| 123 | Thyroid cancer_Homo sapiens_hsa05216 | 0.25412294 |
| 124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25273983 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23069577 |
| 126 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.23059968 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.22988581 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.19487679 |
| 129 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.19435007 |
| 130 | Asthma_Homo sapiens_hsa05310 | 0.18307386 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.17697617 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16156287 |
| 133 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.15977947 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.15460229 |
| 135 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.14941445 |
| 136 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13944092 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.13447370 |
| 138 | Shigellosis_Homo sapiens_hsa05131 | 0.13106857 |
| 139 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.08577561 |

